Clinical and epidemiological data for bone metastases

被引：1
作者：
Debiais, F. [1 ]
机构：
[1] Univ Poitiers, CHU Poitiers, Serv Rhumatol, F-86021 Poitiers, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 03期
关键词：
Bone metastasis; Epidemiology; Skeletal-related events; SKELETAL-RELATED EVENTS; BREAST-CANCER PATIENTS; LONG-TERM EFFICACY; PROGNOSTIC-FACTORS; ZOLEDRONIC ACID; SOLID TUMORS; COMPLICATIONS; MORTALITY; SURVIVAL; CARCINOMA;
D O I：
10.1007/s10269-015-2488-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Bone is a frequent site for metastases in patients with advanced solid tumours, above all concerning prostate, breast, and lung cancers. Bone metastases are often responsible for pain and can be at the origin of skeletal-related events (SRE), associated with morbidity, decrease in quality of life and survival, highlighting the importance of a rapid diagnosis of cancer and treatment in case of bone metastases so as to decrease the risk of these complications.
引用
收藏
页码：63 / 68
页数：6
相关论文
共 50 条
[41]   Epidemiology, management and cost of bone metastases from lung cancer [J].
Decroisette, C. ;
Galerneau, L. -M. ;
Hominal, S. ;
Chouaid, C. .
REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (04) :309-315
[42]   Management of bone metastases from advanced renal cell carcinoma [J].
Khattak, Muhammad Adnan ;
Martin, Hilary Laura .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (16) :3123-3125
[43]   Effect of bisphosphonates on pain and quality of life in patients with bone metastases [J].
Costa, Luis ;
Major, Pierre P. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03) :163-174
[44]   Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach [J].
Jacobson, Dionna ;
Cadieux, Benoit ;
Higano, Celestia S. ;
Henry, David H. ;
Bachmann, Basia A. ;
Rehn, Marko ;
Stopeck, Alison T. ;
Saad, Hossam .
JOURNAL OF BONE ONCOLOGY, 2022, 34
[45]   Bone metastases, general and clinical issues [J].
Greco, C. ;
Forte, L. ;
Erba, P. ;
Mariani, G. .
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (04) :337-352
[46]   Therapeutic Strategies for Bone Metastases and Their Clinical Sequelae in Prostate Cancer [J].
Autio, Karen A. ;
Scher, Howard I. ;
Morris, Michael J. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) :174-188
[47]   Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases [J].
Aapro, Matti ;
Saad, Fred ;
Costa, Luis .
ONCOLOGIST, 2010, 15 (11) :1147-1158
[48]   Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer A French Prospective, Observational, Multicenter Study (GFPC 0601) [J].
Decroisette, Chantal ;
Monnet, Isabelle ;
Berard, Henri ;
Quere, Gilles ;
Le Caer, Herve ;
Bota, Suzanna ;
Audigier-Valette, Clarisse ;
Geriniere, Laurence ;
Vernejoux, Jean-Marc ;
Chouaid, Christos .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) :576-582
[49]   Bone metastases [J].
Coleman, Robert E. ;
Croucher, Peter I. ;
Padhani, Anwar R. ;
Clezardin, Philippe ;
Chow, Edward ;
Fallon, Marie ;
Guise, Theresa ;
Colangeli, Simone ;
Capanna, Rodolfo ;
Costa, Luis .
NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
[50]   Clinical usefulness of bone markers in prostate cancer with bone metastasis [J].
Kamiya, Naoto ;
Suzuki, Hiroyoshi ;
Endo, Takumi ;
Yano, Masashi ;
Naoi, Makito ;
Nishimi, Daisuke ;
Kawamura, Koji ;
Imamoto, Takashi ;
Ichikawa, Tomohiko .
INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (11) :968-979
12345